Analysts Set M.D.C. Holdings, Inc. (MDC) Target Price at $31.75

M.D.C. Holdings, Inc. (NYSE:MDC) has been assigned an average recommendation of “Hold” from the six ratings firms that are presently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $31.75.

A number of equities analysts recently weighed in on the company. Zacks Investment Research raised M.D.C. from a “hold” rating to a “buy” rating and set a $35.00 price objective on the stock in a report on Wednesday, April 10th. Wedbush reissued a “neutral” rating and set a $30.00 price objective on shares of M.D.C. in a report on Wednesday, May 1st. Finally, ValuEngine cut M.D.C. from a “hold” rating to a “sell” rating in a report on Tuesday, January 22nd.

Shares of NYSE:MDC traded up $0.60 on Thursday, hitting $31.95. The company’s stock had a trading volume of 298,000 shares, compared to its average volume of 397,138. M.D.C. has a 1 year low of $25.14 and a 1 year high of $33.47. The stock has a market cap of $1.93 billion, a P/E ratio of 8.71, a PEG ratio of 1.40 and a beta of 1.33. The company has a quick ratio of 2.19, a current ratio of 8.58 and a debt-to-equity ratio of 0.68.

M.D.C. (NYSE:MDC) last released its quarterly earnings results on Tuesday, April 30th. The construction company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.05. M.D.C. had a return on equity of 14.20% and a net margin of 6.90%. The firm had revenue of $647.28 million for the quarter, compared to analysts’ expectations of $597.26 million. During the same quarter last year, the firm posted $0.63 EPS. The company’s revenue was up 6.5% compared to the same quarter last year. On average, equities research analysts expect that M.D.C. will post 3.16 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 29th. Investors of record on Wednesday, May 15th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 3.76%. M.D.C.’s dividend payout ratio is 32.70%.

In related news, COO David D. Mandarich sold 55,000 shares of the firm’s stock in a transaction dated Monday, February 25th. The stock was sold at an average price of $29.65, for a total transaction of $1,630,750.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Chairman Larry A. Mizel sold 35,000 shares of M.D.C. stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $32.46, for a total value of $1,136,100.00. Following the completion of the transaction, the chairman now directly owns 160,958 shares in the company, valued at $5,224,696.68. The disclosure for this sale can be found here. Over the last three months, insiders have sold 341,209 shares of company stock worth $10,352,283. 26.30% of the stock is currently owned by insiders.

Institutional investors have recently made changes to their positions in the business. BlueMountain Capital Management LLC purchased a new position in M.D.C. in the 1st quarter worth approximately $51,000. Penserra Capital Management LLC purchased a new position in M.D.C. in the 1st quarter worth approximately $56,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in M.D.C. by 25.8% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,326 shares of the construction company’s stock worth $93,000 after purchasing an additional 683 shares during the period. Riverhead Capital Management LLC increased its stake in M.D.C. by 7.4% in the 1st quarter. Riverhead Capital Management LLC now owns 4,806 shares of the construction company’s stock worth $140,000 after purchasing an additional 333 shares during the period. Finally, Bank of Montreal Can increased its stake in M.D.C. by 14.1% in the 4th quarter. Bank of Montreal Can now owns 4,908 shares of the construction company’s stock worth $138,000 after purchasing an additional 605 shares during the period. 70.64% of the stock is currently owned by institutional investors and hedge funds.

M.D.C. Company Profile

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

See Also: How a Back-End Load Mutual Fund Works

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.